bpc-157 fda status human use warning What's behind the push to make peptide therapies more readily available : NPR fda warning bpc-157 peptide products
Description
Even though Empower continues to produce tirzepatide by personalizing it for patients, Eli Lillys lawsuit could become a costly and time-consuming battle over that strategy
However, anecdotally, those with Mast Cell or histamine intolerances should be wary and work with a practitioner to prime their immune system with other peptides prior to taking BPC 157
Use with caution if kidney or liver problems
Individual circumstances: While guidelines are in place, a doctor is ultimately responsible for making decisions appropriate for each patient
